Literature DB >> 8266101

Connexin mutations in X-linked Charcot-Marie-Tooth disease.

J Bergoffen1, S S Scherer, S Wang, M O Scott, L J Bone, D L Paul, K Chen, M W Lensch, P F Chance, K H Fischbeck.   

Abstract

X-linked Charcot-Marie-Tooth disease (CMTX) is a form of hereditary neuropathy with demyelination. Recently, this disorder was mapped to chromosome Xq13.1. The gene for the gap junction protein connexin32 is located in the same chromosomal segment, which led to its consideration as a candidate gene for CMTX. With the use of Northern (RNA) blot and immunohistochemistry technique, it was found that connexin32 is normally expressed in myelinated peripheral nerve. Direct sequencing of the connexin32 gene showed seven different mutations in affected persons from eight CMTX families. These findings, a demonstration of inherited defects in a gap junction protein, suggest that connexin32 plays an important role in peripheral nerve.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8266101     DOI: 10.1126/science.8266101

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  206 in total

1.  Targeting motifs and functional parameters governing the assembly of connexins into gap junctions.

Authors:  P E Martin; J Steggles; C Wilson; S Ahmad; W H Evans
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

2.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.

Authors:  I V Mersiyanova; A V Perepelov; A V Polyakov; V F Sitnikov; E L Dadali; R B Oparin; A N Petrin; O V Evgrafov
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

3.  [Defective gap junctions: variability of the phenotype exemplified by connexin 26 mutations].

Authors:  J Krutmann; J O Funk; B Korge
Journal:  Hautarzt       Date:  2002-09       Impact factor: 0.751

4.  Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.

Authors:  Heather M McLaughlin; Reiko Sakaguchi; Cuiping Liu; Takao Igarashi; Davut Pehlivan; Kristine Chu; Ram Iyer; Pedro Cruz; Praveen F Cherukuri; Nancy F Hansen; James C Mullikin; Leslie G Biesecker; Thomas E Wilson; Victor Ionasescu; Garth Nicholson; Charles Searby; Kevin Talbot; Jeffrey M Vance; Stephan Züchner; Kinga Szigeti; James R Lupski; Ya-Ming Hou; Eric D Green; Anthony Antonellis
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

5.  Rapid and direct effects of pH on connexins revealed by the connexin46 hemichannel preparation.

Authors:  E B Trexler; F F Bukauskas; M V Bennett; T A Bargiello; V K Verselis
Journal:  J Gen Physiol       Date:  1999-05       Impact factor: 4.086

6.  GJB1/Connexin 32 whole gene deletions in patients with X-linked Charcot-Marie-Tooth disease.

Authors:  Claudia Gonzaga-Jauregui; Feng Zhang; Charles F Towne; Sat Dev Batish; James R Lupski
Journal:  Neurogenetics       Date:  2010-06-09       Impact factor: 2.660

7.  The role of gap junctions in Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

8.  Inflammatory demyelinating CNS disorder in a case of X-linked Charcot-Marie-Tooth disease: positive response to natalizumab.

Authors:  Jochen H Weishaupt; Claudia Ganser; Mathias Bähr
Journal:  J Neurol       Date:  2012-03-13       Impact factor: 4.849

Review 9.  Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models.

Authors:  Emilie Hoang Dinh; Shoeb Ahmad; Qing Chang; Wenxue Tang; Benjamin Stong; Xi Lin
Journal:  Brain Res       Date:  2009-02-20       Impact factor: 3.252

10.  Injury-triggered Akt phosphorylation of Cx43: a ZO-1-driven molecular switch that regulates gap junction size.

Authors:  Clarence A Dunn; Paul D Lampe
Journal:  J Cell Sci       Date:  2013-11-08       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.